Medical Condition News

RSS

Positron to host special ASNC 2010 symposium focusing on cardiac PET

Positron Corporation is pleased to announce K. Lance Gould M.D. as the keynote speaker for their upcoming cardiac PET symposium, held at the American Society of Nuclear Cardiology annual meeting, September 23-26 in Philadelphia, PA.

30 Aug 2010

Patients with atherothrombosis are at increased risk of ischemic events: Study

Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.

30 Aug 2010

Royal Philips Electronics launches new iE33 xMATRIX cardiac ultrasound system

Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.

From Philips Healthcare 30 Aug 2010

Closing ceremony of heart transplant recipient's 700 km bicycle tour across Canada

Media representatives are invited to join us for the closing ceremony of heart transplant recipient Sylvain Bédard's bicycle tour, to take place at the Montreal Heart Institute (MHI). Dr. Michel Pellerin, the cardiac surgeon who performed the operation, will present him with an official MHI shirt as well as a bouquet of flowers to mark his accomplishment: a tour across Canada, 700 kilometres of which were done on bicycle.

30 Aug 2010

Selective lowering of heart rate reduces risk of death and hospitalization: Study

The results of a major international study presented at the European Society of Cardiology Congress in Stockholm and published simultaneously in The Lancet show, for the first time, that selectively lowering heart rate with a novel medication, ivabradine, significantly reduces risk of death and hospitalization for patients with heart failure. This also resolves a longstanding debate about whether lowering heart rate itself can actually lower the risk of heart disease progression.

30 Aug 2010

Homewatch CareGivers releases new guide related to dementia care

As part of its ongoing program to help caregivers and provide families with the information they need to make informed decisions, Homewatch CareGivers has released its latest resource, entitled "Guide to Living with Dementia." This new guide is available for free download from the company's website.

30 Aug 2010

SQI Diagnostics 2010 third quarter net loss increases to $1,613K

SQI Diagnostics Inc.,a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the third quarter ended June 30, 2010.

30 Aug 2010

Low doses of n-3 fatty acids do not reduce overall rate of major cardiovascular events

Results from the Alpha Omega Trial, a multicentre, placebo-controlled trial in men and women following myocardial infarction (MI), suggest that low doses of n-3 fatty acids given in the form of enriched margarines do not reduce the overall rate of major cardiovascular events.

30 Aug 2010

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

Results from a recent phase 2b clinical trial may provide a new approach to managing excess potassium levels in patients with heart failure and heart failure with chronic kidney disease.

30 Aug 2010

SHIFT study finds Ivabradine reduces heart failure risk

Ivabradine, a selective If inhibitor already investigated for its effects in coronary artery disease and left ventricular dysfunction, significantly lowers the risk of heart failure, according to results of the SHIFT study (Systolic Heart failure treatment with the If inhibitor ivabradine Trial).

30 Aug 2010

AngioDynamics launches new access kit for VenaCure EVLT system to treat varicose veins

AngioDynamics announced today the launch of a new access kit allowing fewer procedure steps and faster procedure time for physicians using the VenaCure EVLT system's NeverTouch® gold-tip laser fiber to treat varicose veins.

30 Aug 2010

Cedillo vs. Health and Human Services case highlights failure of Vaccine Injury Compensation Program

The Elizabeth Birt Center for Autism Law and Advocacy is deeply disappointed in the Court of Appeals for the Federal Circuit's decision to affirm Cedillo v. Secretary of Health and Human Services. EBCALA submitted a friend-of-the-court brief on behalf of 23 civil society organizations in January 2010 urging the Court of Appeals to reverse. In affirming the decision, the Court of Appeals failed to do justice by Michelle Cedillo and thousands of other petitioners in the Omnibus Autism Proceeding (OAP).

30 Aug 2010

Large clinical trial does not confirm benefits of erythropoieitin for first ST-elevation myocardial infarction

Results from the HEBE III study, a prospective, randomised, multicentre trial performed in seven centres in the Netherlands, suggest that the promising effects of erythropoieitin seen in previous smaller studies cannot be confirmed for the improvement of clinical outcome in patients with a first ST-elevation myocardial infarction.

30 Aug 2010

Latest achievements in brain research and treatment for mental disorders

Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.

30 Aug 2010

Jenevieve Fisher to launch book on children living with cancer

Jenevieve Fisher is a children's author with specific expertise in childhood cancer. Her first book "I'm a Kid Living with Cancer" will be launched during September, which is Childhood Cancer Awareness month.

30 Aug 2010

Study finds bone marrow stem cell therapy improves efficacy in chronic heart failure

Bone marrow stem cell therapy improves ventricular performance, quality of life and survival in patients with chronic heart failure, according to results from the STAR-heart study.

30 Aug 2010

23rd ECNP Press conference on impact of circadian rhythms on human brain

All humans are synchronised to the rhythmic light-dark changes that occur on a daily basis. Rhythms in physiological and biochemical processes and behavioural patterns persist in the absence of all external 24-hour signals from the physical environment, with a period that is close to 24 hours

30 Aug 2010

23rd ECNP Congress press conference

The incidence of psychotic disorders varies greatly across places and demographic groups, as do symptoms, course, and treatment response across individuals. High rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatised individuals reflect the causal influence of environmental exposures. This, in combination with progress in the area of molecular genetics, has generated interest in more complicated models of schizophrenia aetiology that explicitly posit gene-environment interactions.

30 Aug 2010

ACTION Ontario encourages provincial narcotics strategy announcement

ACTION Ontario, a non-profit group advocating on behalf of chronic pain sufferers, welcomes the announcement of a provincial narcotics strategy and encourages the government to act on the underlying issue of chronic pain.

30 Aug 2010

US Oncology engages Milliman to develop physician-payer risk contracting model

Innovent Oncology, a subsidiary of US Oncology, has engaged Milliman, a premier global, actuarial and consulting firm, to help develop models in which physician-led oncology organizations can contract around risk, with the intent of negotiating with payers in the first half of 2011.

30 Aug 2010

Medical Condition News

Positron to host special ASNC 2010 symposium focusing on cardiac PET

Patients with atherothrombosis are at increased risk of ischemic events: Study

Royal Philips Electronics launches new iE33 xMATRIX cardiac ultrasound system

Closing ceremony of heart transplant recipient's 700 km bicycle tour across Canada

Selective lowering of heart rate reduces risk of death and hospitalization: Study

Homewatch CareGivers releases new guide related to dementia care

SQI Diagnostics 2010 third quarter net loss increases to $1,613K

Low doses of n-3 fatty acids do not reduce overall rate of major cardiovascular events

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

SHIFT study finds Ivabradine reduces heart failure risk

AngioDynamics launches new access kit for VenaCure EVLT system to treat varicose veins

Cedillo vs. Health and Human Services case highlights failure of Vaccine Injury Compensation Program

Large clinical trial does not confirm benefits of erythropoieitin for first ST-elevation myocardial infarction

Latest achievements in brain research and treatment for mental disorders

Jenevieve Fisher to launch book on children living with cancer

Study finds bone marrow stem cell therapy improves efficacy in chronic heart failure

23rd ECNP Press conference on impact of circadian rhythms on human brain

23rd ECNP Congress press conference

ACTION Ontario encourages provincial narcotics strategy announcement

US Oncology engages Milliman to develop physician-payer risk contracting model

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News